| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |